Clinical efficacy of potassium humate in the treatment of allergic rhinitis: double-blind placebo-controlled trial

The clinical efficacy of potassium humate in the treatment of allergic rhinitis: A double blind placebo controlled trial

Methoxsalen bath in the treatment of palmoplantar Eczema: A double-blind, placebo controlled clinical trial

Background: Palmoplantar eczema is a common clinical problem involving 2% of the population. There are many treatment modalities for palmoplantar eczema, each with specific local and systemic side effects. Objective: To evaluate methoxsalen bath in the treatment of palmoplantar eczema. Patients and Methods: In a randomized, double-blind, placebo controlled clinical trial, 60 patients with palmo...

Efficacy of Supportive Therapy of Allergic Rhinitis by Stinging Nettle (Urtica dioica) root extract: a randomized, double-blind, placebo-controlled clinical trial

In this study, we aimed at studying the benefit of Urtica dioica root extract in the management of allergic rhinitis. In a randomized double blind clinical trial, 74 patients with the signs and symptoms of allergic rhinitis and a positive skin prick test were randomly divided into 2 groups. The study group was treated with routine allergic rhinitis treatment and Nettle root extract (Urtidin®, B...

Efficacy of Supportive Therapy of Allergic Rhinitis by Stinging Nettle (Urtica dioica) root extract: a randomized, double-blind, placebo-controlled clinical trial

In this study, we aimed at studying the benefit of Urtica dioica root extract in the management of allergic rhinitis. In a randomized double blind clinical trial, 74 patients with the signs and symptoms of allergic rhinitis and a positive skin prick test were randomly divided into 2 groups. The study group was treated with routine allergic rhinitis treatment and Nettle root extract (Urtidin®, B...

Efficacy of Nasal Cellulose Powder in the Symptomatic Treatment of Allergic Rhinitis: A Randomized, Double-Blind, Placebo-Controlled Trial

PURPOSE Nasal Cellulose Powder (NCP), which can prevent from binding an allergen to nasal mucosa, may reduce allergic rhinitis (AR) symptoms in dust mite-sensitized children. This study was conducted to assess the efficacy of NCP in improving clinical symptoms of a nasal airflow limitation and the response of nasal inflammatory cells. METHODS Children with dust mite-sensitized AR aged 6-18 ye...